Ph III HFrEF study
Research payments
$60,093
Through program year 2025, $60,093 in research payments was reported against Ph III HFrEF study, across 9 payments, paid by Boehringer Ingelheim Pharma GmbH & Co.KG.
- Paid by
- Boehringer Ingelheim Pharma GmbH & Co.KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $60,093 | 9 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jonathan Yousef Wesley Chapel, FL Named on 1 payment
- David Hotchkiss Port Charlotte, FL Named on 1 payment
- Anil Chhabra Shreveport, LA Named on 1 payment
- Harvey Serota Saint Louis, MO Named on 1 payment
- Mark Koch Fort Worth, TX Named on 1 payment
- Heather Shenkman Tarzana, CA Named on 1 payment
- Aamir Jamal San Dimas, CA Named on 1 payment
- Zulfiquar Bhatti Columbus, GA Named on 1 payment
- Geetha Reddy Libertyville, IL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.